Mussa, A.; Afolabi, H.A.; Syed, N.H.; Talib, M.; Murtadha, A.H.; Hajissa, K.; Mokhtar, N.F.; Mohamud, R.; Hassan, R.
The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer. Biomedicines 2023, 11, 1060.
https://doi.org/10.3390/biomedicines11041060
AMA Style
Mussa A, Afolabi HA, Syed NH, Talib M, Murtadha AH, Hajissa K, Mokhtar NF, Mohamud R, Hassan R.
The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer. Biomedicines. 2023; 11(4):1060.
https://doi.org/10.3390/biomedicines11041060
Chicago/Turabian Style
Mussa, Ali, Hafeez Abiola Afolabi, Nazmul Huda Syed, Mustafa Talib, Ahmad Hafiz Murtadha, Khalid Hajissa, Noor Fatmawati Mokhtar, Rohimah Mohamud, and Rosline Hassan.
2023. "The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer" Biomedicines 11, no. 4: 1060.
https://doi.org/10.3390/biomedicines11041060
APA Style
Mussa, A., Afolabi, H. A., Syed, N. H., Talib, M., Murtadha, A. H., Hajissa, K., Mokhtar, N. F., Mohamud, R., & Hassan, R.
(2023). The NF-κB Transcriptional Network Is a High-Dose Vitamin C-Targetable Vulnerability in Breast Cancer. Biomedicines, 11(4), 1060.
https://doi.org/10.3390/biomedicines11041060